Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Post by rjc7on May 27, 2015 11:20am
164 Views
Post# 23769404

By special invitation......nice.

By special invitation......nice.

Microbix Invited to Present at 2015 LD Micro Investor Conference

CNCN

Microbix Invited to Present at 2015 LD Micro Investor Conference
Microbix Invited to Present at 2015 LD Micro Investor Conference
TORONTO, ONTARIO--(Marketwired - May 27, 2015) - Microbix Biosystems Inc. (TSX:MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today announced that its Chief Executive Officer, Vaughn Embro-Pantalony, will present an update of the Company's business at the 2015 LD Micro Invitational Conference on Wednesday, June 3, 2015 at 8:00 a.m. Pacific Time. The conference will be held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
Mr. Embro-Pantalony's presentation will be webcast live and archived for at least 90 days on the Company's website at https://www.microbix.com under the "Events" listing in the Investors section.
About LD Micro
LD Micro publishes an online investment newsletter that provides self-directed investors with information on selected public companies in North America that, in the opinion of LD Micro, have strong investment potential. LD Micro is a non-registered investment advisor. Since 2008, LD Micro has been hosting private investor conferences where target companies are invited to present. This year 185 companies will be presenting, with over 1,000 people participating.
Bullboard Posts